3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
2
Status
Terminated
4
Not yet recruiting
2
Active not recruiting
2
Withdrawn
1
Unknown
1
Suspended
1
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
CNS
2
Sarcoma
1
Conditions
Leukemia, Myeloid, Acute
17
Precursor Cell Lymphoblastic Leukemia-Lymphoma
16
Myelodysplastic Syndromes
16
Leukemia, Lymphocytic, Chronic, B-Cell
13
Lymphoma, Non-Hodgkin
10
Lymphoma
9
Multiple Myeloma
8
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
8
Leukemia
8
Recurrence
6
Hodgkin Disease
6
Myeloproliferative Disorders
5
Lymphoma, Mantle-Cell
5
Lymphoma, B-Cell
5
Leukemia, Biphenotypic, Acute
5
Neoplasms
4
Neoplasm, Residual
4
Melanoma
4
Lymphoma, Large B-Cell, Diffuse
4
Lymphoma, Follicular
4
Leukemia, Myelomonocytic, Juvenile
4
Leukemia, Lymphoid
4
Immunoproliferative Disorders
4
Immune System Diseases
4
Burkitt Lymphoma
4
Precancerous Conditions
3
Lymphoproliferative Disorders
3
Lymphoma, B-Cell, Marginal Zone
3
Lymphatic Diseases
3
Leukemia, Myelomonocytic, Chronic
3
Interventions
Cyclophosphamide
10
Magnetic Resonance Spectroscopy
8
Temozolomide
6
Biopsy
6
dinutuximab
5
X-Rays
5
Topotecan
5
Specimen Handling
5
Phantoms, Imaging
5
Nuclear Medicine Department, Hospital
5
Irinotecan
5
Etoposide
3
Colony-Stimulating Factors
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
sargramostim
2
pembrolizumab
2
palbociclib
2
naxitamab
2
larotrectinib
2
ivosidenib
2
fludarabine phosphate
2
fludarabine
2
etoposide phosphate
2
erdafitinib
2
ensartinib
2
Lenalidomide
2
Isotretinoin
2
Granulocyte-Macrophage Colony-Stimulating Factor
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Active not recruiting
×
Neuroblastoma
×
fludarabine phosphate
×
Clear all
NCT01953900
2026-04-22
VEGAS
Baylor College of Medicine
Phase 1
Active not recruiting
26 enrolled
NCT01822652
2026-04-06
GRAIN
Baylor College of Medicine
Phase 1
Active not recruiting
11 enrolled